Maria L. Freilino

Medicine · Health Sciences

20h-index2.9kcitations96works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytokine Signaling Pathways and Interactions(35), RNA modifications and cancer(32), Lung Cancer Treatments and Mutations(28), PI3K/AKT/mTOR signaling in cancer(19), MicroRNA in disease regulation(13)

Publications96 total

Supplementary Figure 6 from Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer
2023Open Access
Data from Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer
2023Open Access
Supplementary Figures from Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
2023Open Access
Supplementary Figure 2 from First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
2023Open Access
Data from Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
2023Open Access
Supplementary Figure Legend from Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer
2023Open Access
Supplementary Figure 2 from First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
2023Open Access
Supplementary Figure 5 from First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
2023Open Access
Supplementary Figures from Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
2023Open Access
Data from STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell Carcinoma
2023Open Access
Supplementary Table 1 from Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer
2023Open Access
Supplementary Figure 6 from Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer
2023Open Access
Data from Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer
2023Open Access
Supplementary Figure 6 from First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
2023Open Access
Supplementary Figure 7 from First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
2023Open Access
Supplementary Figure 2 from Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer
2023Open Access
Supplementary Figure Legend from Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer
2023Open Access
Supplementary Figure 6 from First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
2023Open Access
Supplementary Tables from Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
2023Open Access
Supplementary Figure 5 from Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Jennifer R. Grandis(43), Sufi M. Thomas(31), Malabika Sen(22), Sonali Joyce(20), William E. Gooding(19), Changyou Li(14), Simion I. Chiosea(13), Raja R. Seethala(13), Daniel E. Johnson(12), Robert L. Ferris(11), Neil E. Bhola(11), Vivian Wai Yan Lui(10), Seungwon Kim(10), Umamaheswar Duvvuri(10), Anirban Sahu(10), Yan Zeng(9), Noah D. Peyser(9), Ching‐Shih Chen(8), Matthew L. Hedberg(7), Brenda Diergaarde(7)